Scarica l'app Stockscreener
345.38
3.80%
-13.64
Dopo l'orario di chiusura:
345.38
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$359.02
Aprire:
$358.37
Volume 24 ore:
620.99K
Relative Volume:
1.14
Capitalizzazione di mercato:
$20.56B
Reddito:
$2.91B
Utile/perdita netta:
$622.64M
Rapporto P/E:
32.96
EPS:
10.48
Flusso di cassa netto:
$620.14M
1 W Prestazione:
-0.02%
1M Prestazione:
+3.48%
6M Prestazione:
-8.32%
1 anno Prestazione:
-3.79%
Intervallo 1D:
$344.82
$358.37
Intervallo di 1 settimana:
$343.15
$368.02
Portata 52W:
$279.24
$423.56
Waters Corp Stock (WAT) Company Profile
Nome
Waters Corp
Settore
Industria
Telefono
(508) 478-2000
Indirizzo
34 MAPLE ST, MILFORD, MA
Confronta WAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
345.38 | 20.56B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
406.05 | 153.96B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
187.82 | 138.19B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
509.42 | 39.13B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.52 | 30.65B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
141.82 | 26.52B | 15.50B | 1.33B | 2.16B | 7.34 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-31 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-01 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2023-11-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-05-18 | Iniziato | Barclays | Overweight |
| 2022-05-17 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Aggiornamento | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Aggiornamento | Citigroup | Sell → Neutral |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Downgrade | Needham | Hold → Underperform |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Sell |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-09 | Downgrade | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-01-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Iniziato | Needham | Hold |
| 2018-12-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Downgrade | Goldman | Neutral → Sell |
| 2018-10-11 | Aggiornamento | Cleveland Research | Sell → Neutral |
Mostra tutto
Waters Corp Borsa (WAT) Ultime notizie
Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance - The Manila Times
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
What Makes Waters Corporation (WAT) a Lucrative Investment? - Yahoo Finance
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT St - GuruFocus
Analyst Expectations For Waters's Future - Benzinga
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT Stock News - GuruFocus
UBS Lowers Price Target for Waters (WAT) to $360 | WAT Stock New - GuruFocus
UBS Adjusts Price Target for Waters (WAT) Following Strong Quarter | WAT Stock News - GuruFocus
Analyst Boosts Price Target for Waters (WAT) Following Strong Q1 Results | WAT Stock News - GuruFocus
Waters Corporation (NYSE:WAT) Q1 2025 Earnings Call Transcript - Insider Monkey
Barclays Adjusts Price Target for Waters (WAT) Following Q1 Results | WAT Stock News - GuruFocus
Datadog, Masimo, Waters - TradingView
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instrument Sales and Raised Guidance ... - Yahoo Finance
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instr - GuruFocus
Waters Corporation Reports Strong Q1 2025 Results - TipRanks
Decoding Waters Corp (WAT): A Strategic SWOT Insight - GuruFocus
Waters: Q1 Earnings Snapshot - CTPost
Waters Corp Earnings Call: Strong Growth Amid Challenges - TipRanks
Waters Corporation: Still A Hold After Q1 Earnings (NYSE:WAT) - Seeking Alpha
Waters Earnings: Fair Value Estimate Up Amid Strong Start to 2025, Including Higher Instrument Sales - Morningstar
Waters Is Recovering Following a Post-Pandemic Reset Period - Morningstar
Waters (WAT) Exceeds Q1 Revenue Forecasts with Strong Performanc - GuruFocus
Waters Corp. (WAT) Anticipates Strong Sales Growth in Q2 2025 | - GuruFocus
Waters Corp Lifts Profit Forecast After Strong Demand In Asia And Americas - Finimize
Waters Corp (WAT) Q1 2025 Earnings: Revenue Surpasses Estimates at $662M, GAAP EPS Slightly Misses at $2.03 - GuruFocus
Waters Integrates Multi-Angle Light Scattering Detectors with Em - GuruFocus
Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance – Company AnnouncementFT.com - Financial Times
Waters Corp. Q1 Profit Increases, Beats Estimates - Nasdaq
Waters Breakthrough: 6-Month Validation Time Savings for Biopharma Quality Control Testing - Stock Titan
What To Expect From Waters Corporation’s (WAT) Q1 Earnings - Yahoo Finance
Assessing Risky S&P 500 Stocks: EPAM, HPE, and Waters CorpNews and Statistics - IndexBox
Waters Corp (WAT) Stock Price Up 4.63% on Apr 22 - GuruFocus
Is There An Opportunity With Waters Corporation's (NYSE:WAT) 25% Undervaluation? - Yahoo Finance
Waters (WAT) Sees Price Target Reduction by Baird Ahead of Q1 Results | WAT Stock News - GuruFocus
Chromatography Market to Reach $14.37 Billion, Globally, by 2032 at 5.3% CAGR: Coherent Market Insights - GlobeNewswire Inc.
Waters Corp. stock underperforms Tuesday when compared to competitors - MSN
Waters Corp (WAT) Faces Lowered Price Target Amid Industry Conce - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corporation Q1 Earnings: Global Analytics Leader Sets Key Investor Date - Stock Titan
Option oneJoint waters company with Waikato District Council - Hamilton City Council
Waters expands Alliance iS Bio HPLC product line with Photodiode Array Detector for biopharma development & QC - SelectScience
Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit - ET HealthWorld
Waters (NYSE:WAT) Expands Bio HPLC Line With PDA Detection Enhancing Lab Efficiency - Yahoo Finance
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC – Company AnnouncementFT.com - Financial Times
Waters Revolutionizes Biopharma Testing: New HPLC System Achieves 80x Sensitivity Boost - Stock Titan
KeyBanc raises Waters Corp. stock rating to Overweight By Investing.com - Investing.com Canada
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom By Investing.com - Investing.com South Africa
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
KeyBanc raises Waters Corp. stock rating to Overweight - Investing.com
Waters Corp Azioni (WAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):